Fortress Biotech (FBIO) Non Operating Interest Expenses (2010 - 2026)
Powered by 
Analysis
Fortress Biotech (FBIO) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | 1.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.48 Mn |
| Dec 31, 2025 | 2.04 Mn |
| Sep 30, 2025 | 2.74 Mn |
| Jun 30, 2025 | 2.52 Mn |
| Mar 31, 2025 | 2.81 Mn |
| Dec 31, 2024 | 2.59 Mn |
| Sep 30, 2024 | 6.21 Mn |
| Jun 30, 2024 | 2.12 Mn |
| Mar 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 2.06 Mn |
| Sep 30, 2023 | 2.53 Mn |
| Jun 30, 2023 | 6.43 Mn |
| Mar 31, 2023 | 4.30 Mn |
| Dec 31, 2022 | 4.75 Mn |
| Sep 30, 2022 | 3.39 Mn |
| Jun 30, 2022 | 3.15 Mn |
| Mar 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | 5.92 Mn |
| Sep 30, 2021 | 4.44 Mn |
| Jun 30, 2021 | 2.76 Mn |